Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$714M Sell
2,023,367
-3,857
-0.2% -$1.38M 0.17% 127
2025
Q4
$664M Buy
2,027,224
+26,278
+1% +$8.34M 0.15% 135
2025
Q3
$564M Sell
2,000,946
-467,013
-19% -$135M 0.13% 164
2025
Q2
$689M Buy
2,467,959
+345,242
+16% +$97.8M 0.17% 123
2025
Q1
$663M Buy
2,122,717
+96,851
+5% +$28.6M 0.18% 124
2024
Q4
$527M Buy
2,025,866
+84,128
+4% +$25M 0.14% 164
2024
Q3
$626M Sell
1,941,738
-2,225
-0.1% -$728K 0.16% 139
2024
Q2
$608M Sell
1,943,963
-30,634
-2% -$9M 0.16% 134
2024
Q1
$561M Sell
1,974,597
-192,288
-9% -$56.3M 0.15% 145
2023
Q4
$624M Buy
2,166,885
+39,417
+2% +$10.7M 0.19% 118
2023
Q3
$574M Buy
2,127,468
+81,655
+4% +$20.4M 0.19% 112
2023
Q2
$452M Buy
2,045,813
+200,755
+11% +$46.6M 0.14% 154
2023
Q1
$445M Sell
1,845,058
-60,428
-3% -$14.8M 0.15% 157
2022
Q4
$501M Buy
1,905,486
+271,833
+17% +$72.9M 0.17% 131
2022
Q3
$370M Sell
1,633,653
-46,113
-3% -$11.2M 0.14% 170
2022
Q2
$408M Sell
1,679,766
-80,744
-5% -$19.8M 0.14% 152
2022
Q1
$417M Sell
1,760,510
-48,667
-3% -$11.2M 0.12% 175
2021
Q4
$397M Buy
1,809,177
+523,894
+41% +$111M 0.11% 191
2021
Q3
$272M Sell
1,285,283
-176,347
-12% -$40.6M 0.09% 247
2021
Q2
$355M Buy
1,461,630
+18,811
+1% +$4.63M 0.11% 192
2021
Q1
$359M Buy
1,442,819
+67,404
+5% +$16.1M 0.12% 179
2020
Q4
$316M Sell
1,375,415
-219,017
-14% -$50.5M 0.11% 193
2020
Q3
$406M Buy
1,594,432
+70,268
+5% +$17.4M 0.17% 130
2020
Q2
$360M Sell
1,524,164
-267,020
-15% -$60.9M 0.15% 141
2020
Q1
$364M Sell
1,791,184
-142,842
-7% -$31.2M 0.19% 118
2019
Q4
$468M Buy
1,934,026
+289,519
+18% +$63.8M 0.19% 108
2019
Q3
$319M Sell
1,644,507
-145,432
-8% -$27.9M 0.14% 154
2019
Q2
$330M Sell
1,789,939
-111,307
-6% -$19.9M 0.15% 151
2019
Q1
$361M Buy
1,901,246
+180,926
+11% +$34.6M 0.17% 129
2018
Q4
$336M Buy
1,720,320
+20,781
+1% +$4.05M 0.17% 127
2018
Q3
$397M Buy
1,699,539
+4,638
+0.3% +$914K 0.14% 167
2018
Q2
$314M Sell
1,694,901
-14,217
-0.8% -$2.51M 0.14% 159
2018
Q1
$291M Sell
1,709,118
-72,383
-4% -$13.3M 0.13% 170
2017
Q4
$309M Sell
1,781,501
-183,907
-9% -$32.5M 0.14% 161
2017
Q3
$367M Sell
1,965,408
-193,423
-9% -$34.3M 0.17% 123
2017
Q2
$373M Buy
2,158,831
+679,144
+46% +$110M 0.19% 120
2017
Q1
$243M Buy
1,479,687
+10,109
+0.7% +$1.68M 0.13% 174
2016
Q4
$214M Sell
1,469,578
-54,241
-4% -$8.16M 0.12% 179
2016
Q3
$255M Buy
1,523,819
+52,518
+4% +$8.88M 0.14% 152
2016
Q2
$223M Buy
1,471,301
+198,911
+16% +$30.9M 0.13% 168
2016
Q1
$191M Sell
1,272,390
-223,615
-15% -$33.2M 0.11% 187
2015
Q4
$243M Buy
1,496,005
+37,558
+3% +$5.9M 0.14% 149
2015
Q3
$202M Sell
1,458,447
-207,451
-12% -$32.7M 0.12% 161
2015
Q2
$256M Sell
1,665,898
-832,701
-33% -$133M 0.15% 147
2015
Q1
$399M Sell
2,498,599
-1,831,312
-42% -$288M 0.23% 98
2014
Q4
$690M Sell
4,329,911
-57,924
-1% -$9.03M 0.4% 54
2014
Q3
$616M Buy
4,387,835
+146,439
+3% +$19.1M 0.37% 58
2014
Q2
$502M Sell
4,241,396
-1,848,066
-30% -$214M 0.3% 76
2014
Q1
$751M Buy
6,089,462
+276,029
+5% +$33.5M 0.45% 38
2013
Q4
$664M Buy
5,813,433
+568,872
+11% +$64.7M 0.4% 43
2013
Q3
$587M Sell
5,244,561
-47,212
-0.9% -$5.12M 0.39% 45
2013
Q2
$522M Buy
+5,291,773
New +$549M 0.36% 51

Other funds holding AMGN

Ameriprise's AMGN Position: Q1 2026 in Review

Ameriprise reduced its Amgen (AMGN) stake by 0.19% in Q1 2026, selling an estimated $1.38M and leaving 2,023,367 shares worth $714M. The position accounts for 0.17% of the portfolio, ranked #127.

Ameriprise first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $751M in Q1 2014. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Ameriprise held 2,023,367 shares of Amgen worth $714M as of Q1 2026.
  • Ameriprise sold 3,857 Amgen shares in Q1 2026, an estimated $1.38M.
  • Amgen made up 0.17% of Ameriprise's portfolio in Q1 2026, its #127 holding.
  • Ameriprise first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Amgen position peaked at $751M in Q1 2014.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.